3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
7
Phase 3
6
Phase 2/3
1
Phase 1
1
Status
Terminated
2
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Anus Neoplasms
1
Interventions
Cisplatin
13
Paclitaxel
11
Cyclophosphamide
11
Doxorubicin
10
Magnetic Resonance Spectroscopy
9
Gemcitabine
9
Prednisone
8
Docetaxel
8
Specimen Handling
7
Oxaliplatin
7
Carboplatin
7
Vincristine
6
Etoposide
6
Capecitabine
6
pembrolizumab
5
Rituximab
5
Radiotherapy
5
Leucovorin
5
Cytarabine
5
Bevacizumab
5
atezolizumab
4
Trastuzumab
4
Platinum
4
Nivolumab
4
Fluorouracil
4
Dexamethasone
4
Biopsy
4
1,2-diaminocyclohexaneplatinum II citrate
4
Watchful Waiting
3
Taxes
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Active not recruiting
×
Mitomycin
×
Clear all
NCT05902533
2025-12-18
REDEL
University of Cincinnati
Phase 2/3
Active not recruiting
33 enrolled